6
Participants
Start Date
May 31, 2013
Primary Completion Date
November 30, 2014
Study Completion Date
February 28, 2015
PSMA ADC
2.5 mg/kg, IV, over 60 minutes every 3 weeks
UT Southwestern, Dallas
Rhode Island Hospital, Providence
Progenics Pharmaceuticals, Inc.
INDUSTRY
Rhode Island Hospital
OTHER
University of Texas
OTHER
Heinrich Elinzano, MD
OTHER